To evaluate the robustness and clinical relevance of MGMT-Net beyond internal validation frameworks, we assessed its performance on an external dataset of 200 glioma cases from three institutions: UCSF, NYU, and UTSW. Here, MGMT is linked to central nervous system cancer.